Human Medicines (Amendments Relating to Coronavirus and Influenza) (England and Wales and Scotland) Regulations 2024 Work package

A work package focussed on the Human Medicines (Amendments Relating to Coronavirus and Influenza) (England and Wales and Scotland) Regulations 2024, made available on 10 January 2024, subject to the Draft affirmative procedure.

There are 15 business items actualising 19 steps.

RSS

Business items having happened

10 January 2024
23 January 2024
1. Considered by the Secondary Legislation Scrutiny Committee (SLSC) (House of Lords)
  Noted as an instrument of interest by the Secondary Legislation Scrutiny Committee (SLSC) (House of Lords)
24 January 2024
1. Considered by the Joint Committee on Statutory Instruments (JCSI) (House of Commons and House of Lords)
  Instrument not drawn to the special attention of the Houses by the Joint Committee on Statutory Instruments (JCSI) (House of Commons and House of Lords)
30 January 2024
1. Delegated Legislation Committee (DLC) debate (House of Commons)
31 January 2024
1. Question on motion to approve the instrument put (House of Commons)
  Instrument approved (House of Commons)
21 February 2024
1. Motion to approve the instrument tabled by the Government (House of Lords)
27 February 2024
1. Grand Committee debate (House of Lords)
28 February 2024
6 March 2024
1. Instrument made (signed into law)
31 March 2024
1. Instrument comes into force as law

Work package identifier

https://id.parliament.uk/gVmu6DNd

SPARQL queries used by this page

PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>
      PREFIX : <https://id.parliament.uk/schema/>
      PREFIX id: <https://id.parliament.uk/>
      SELECT * where {
  
       ?Paper a :WorkPackagedThing .  
           ?Paper :name ?Papername ;
           :workPackagedThingHasWorkPackage ?workPackage.
        filter (?workPackage IN (id:gVmu6DNd))
           ?workPackage :workPackageHasBusinessItem ?businessItem. 
           ?workPackage :workPackageHasProcedure ?procedure.
         optional {?businessItem :businessItemDate ?businessItemDate}
        optional {?businessItem :businessItemHasBusinessItemWebLink ?businessItemLink}
       ?businessItem :businessItemHasProcedureStep ?businessItemProcedureStep. 
       ?businessItemProcedureStep :name ?businessItemProcedureStepName.
       ?businessItemProcedureStep :procedureStepHasStepDisplayDepthInProcedure ?stepDepth.
        ?procedure :procedureHasStepDisplayDepthInProcedure ?stepDepth.
       ?stepDepth :stepDisplayDepthInProcedureHasDepth ?depthValue.
        Optional {?businessItemProcedureStep :procedureStepInLegislature ?legislature.
          ?legislature :name ?legislatureName.}
        Optional {?businessItemProcedureStep :procedureStepHasHouse ?CommonsId.
              filter (?CommonsId IN (id:1AFu55Hs))}
        Optional {?businessItemProcedureStep :procedureStepHasHouse ?LordsId.
          filter (?LordsId IN (id:WkUWUBMx))} }  order by ?businessItemDate ?depthValue ?businessItem

Human Medicines (Amendments Relating to Coronavirus and Influenza) (England and Wales and Scotland) Regulations 2024 Work package

Business items having happened

10 January 2024

23 January 2024

24 January 2024

30 January 2024

31 January 2024

21 February 2024

27 February 2024

28 February 2024

6 March 2024

31 March 2024

Work package identifier